-

Komodo Health, Blue Health Intelligence Reach Litigation Resolution

SAN FRANCISCO--(BUSINESS WIRE)--Healthcare technology company Komodo Health announced today that Komodo Health and Blue Health Intelligence (BHI) have settled litigation resolving an ongoing dispute. The settlement dismisses the litigation with no admission or finding of liability by either party.

“We are pleased with this outcome and look forward to focusing on the important work of helping our valued customers better serve their patients,” stated Komodo Health Chief Executive Officer Arif Nathoo, MD.

“As a leader in providing comprehensive health insights, our goal – from day one – has been to raise the bar and challenge our industry to think differently. We look forward to the next phase of our relationship with BHI,” added Dr. Nathoo.

About Komodo Health

Komodo Health is a technology platform company creating the new standard for real-world data and analytics by pairing the industry’s most complete view of patient encounters with artificial intelligence to connect the dots between individual patient journeys and large-scale health outcomes. Across Life Sciences, payers, providers, and developers, Komodo helps its customers unearth patient-centric insights at scale — marrying clinical data with advanced algorithms and AI-powered software solutions to inform decision-making, close gaps in care, address disease burden, and help enterprises create a more cost-effective, value-driven healthcare system. For more information, visit komodohealth.com.

Komodo Health


Release Versions

More News From Komodo Health

Komodo Health Appoints Mark Jewett to Chief Marketing Officer

NEW YORK & SAN FRANCISCO--(BUSINESS WIRE)--Komodo Health, the leader in AI-powered healthcare intelligence, today announced the appointment of Mark Jewett as Chief Marketing Officer (CMO). Jewett will lead the company’s marketing, shaping brand, communications, and go-to-market strategy as it scales Marmot™ — its new AI platform designed to help Life Sciences and healthcare organizations innovate faster and serve patients better. The appointment comes following a period of significant momentum...

Komodo Health Analysis Uncovers Dual Reality in Metastatic Breast Cancer Care: Rapid Targeted Cancer Therapy Adoption Amid Glaring Age-Related Disparities

NEW YORK & SAN FRANCISCO--(BUSINESS WIRE)--On the 40th anniversary of Breast Cancer Awareness Month, a new analysis from Komodo Health, the leader in AI-powered healthcare intelligence, conducted in collaboration with the Tigerlily Foundation, a national breast cancer patient advocacy organization, delivers critical insights into antibody-drug conjugate (ADC) treatment patterns in metastatic breast cancer. The study confirms growing clinical acceptance of this innovative therapy but also reveal...

Komodo Health Recognized by Forbes, TIME, and The Healthcare Technology Report for Healthcare Analytics AI Innovation

NEW YORK & SAN FRANCISCO--(BUSINESS WIRE)--Komodo Health, the leader in AI-powered healthcare intelligence, today announced that it has earned recognition on three prestigious industry lists: the 2025 Forbes Cloud 100, TIME’s inaugural World’s Top HealthTech Companies, and The Healthcare Technology Report’s Top 25 Healthcare Software Companies. These honors validate Komodo’s differentiated approach to healthcare analytics AI — purpose-built from the ground up rather than retrofitted from consum...
Back to Newsroom